Bismuth Nitrate

OTHER NAME(S): Bismuth(III) Nitrate, Bismuth Trinitrate, Nitric Acid (Bismuth(u003Cnorefu003E3+u003C/norefu003E) salt), Bismuth Trinitrate Pentahydrate, Bismuth(III) Nitrate Pentahydrate, Bismuth nitrate, Nitrato de bismuto, Nitrate de bismuth

Overview

Bismuth nitrate is a salt. It contains the heavy metal bismuth.

People use bismuth nitrate for preventing kidney damage caused by cancer drugs, for preventing bone marrow damage caused by radiation, and for a digestive tract infection that can lead to ulcers (Helicobacter pylori or H. pylori), but there is no good scientific evidence to support these uses.

Bismuth nitrate causes some cells to make a protein called metallothionein. This protein protects the cells from damage caused by free radicals.

Bismuth nitrate is used in cosmetics as a pigment.

In December 2019, the U.S. Food and Drug Administration added bismuth nitrate to the Dietary Supplement Ingredient Advisory List. The ingredients on this list might not be lawful to include in dietary supplements. For this reason, people may want to avoid using supplements containing bismuth nitrate.

Do not confuse bismuth nitrate with other bismuth salts. See separate listing for bismuth.

Bismuth nitrate causes some cells to make a protein called metallothionein. This protein protects the cells from damage caused by free radicals.

References
  1. U.S. Food & Drug Administration. Dietary supplement ingredient advisory list. https://www.fda.gov/food/dietary-supplement-products-ingredients/dietary-supplement-ingredient-advisory-list. Accessed December 17, 2019.
  2. - Jaeger A, Kopferschmitt J, Sauder Ph, Flesch F, Tournoud C. Diagnosis in clinical toxicology. In: Bolt HM, de Wolff FA, Henderson PT (eds) Medical Toxicology. Archives of Toxicology (Supplement). Berlin/Heidelberg, Germany: Springer-Verlag; 1992:29-39.
  3. Kagimoto O, Naganuma A, Imura N, et al. Effect of the administration of bismuth nitrate on radiogenic thymoma induction in mice. J Radiat Res. 1991;32(4):417-28.
  4. Kaji T, Suzuki M, Yamamoto C, et al. Induction of metallothionein synthesis by bismuth in cultured vascular endothelial cells. Res Commun Mol Pathol Pharmacol. 1994;86(1):25-35.
  5. Kaji T, Mishima A, Yamamoto C, et al. Bismuth induces metallothionein but does not protect against cadmium cytotoxicity in cultured vascular endothelial cells. Bull Environ Contam Toxicol. 1996;56(4):630-4.
  6. Kondo Y, Satoh M, Imura N, Akimoto M. Effect of bismuth nitrate given in combination with cis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother Pharmacol. 1991;29(1):19-23.
  7. Liu Y, Shen C, Zhang X, et al. Exposure and nephrotoxicity concern of bismuth with the occurrence of autophagy. Toxicol Ind Health. 2018;34(3):188-199.
  8. Miura N, Satoh M, Imura N, Naganuma A. Protective effect of bismuth nitrate against injury to the bone marrow by gamma-irradiation in mice: possible involvement of induction of metallothionein synthesis. J Pharmacol Exp Ther. 1998;286(3):1427-30.
  9. Bismuth nitrate; MSDS No. B3396 [Online]; Mallenckrodt Baker: Phillipsburg, NJ, December 8, 1996. https://hazard.com/msds/mf/baker/baker/files/b3396.htm (accessed December 27, 2019).
  10. Saberi-Firoozi M, Massarrat S, Zare S, et al. Effect of triple therapy or amoxycillin plus omeprazole or amoxycillin plus tinidazole plus omeprazole on duodenal ulcer healing, eradication of Helicobacter pylori, and prevention of ulcer relapse over a 1-year follow-up period: a prospective, randomized, controlled study. Am J Gastroenterol. 1995;90(9):1419-23.
  11. Satoh M, Aoki Y, Tohyama C. Protective role of metallothionein in renal toxicity of cisplatinum. Cancer Chemother Pharmacol. 1997;40(4):358-62.
  12. Von Bose MJ, Zaudig M. Encephalopathy resembling Creutzfeldt-Jakob disease following oral, prescribed doses of bismuth nitrate. Br J Psychiatry. 1991;158:278-80.
  13. Lewis RJ Sr. Hazardous Chemicals Desk Reference. 6th Edition. Hoboken, NJ: Wiley; 2008.
  14. Raafat BM, Samir WA, Khader MH. Met-Hemoglobin concentration reduction and methemoglobin reductase enhancement after applying of alpha-tocopherol and selenium combination as a radio protector against ionizing radiation exposure. Wulfenia J. 2012;19(10):373-389.